NCT06207175 2024-01-23
A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine
Beijing Health Guard Biotechnology, Inc
Phase 3 Unknown
Beijing Health Guard Biotechnology, Inc
Wuhan BravoVax Co., Ltd.
Beijing Health Guard Biotechnology, Inc